New Protocol on Human Malignant B Cell Chemotaxis
A new protocol on chemotaxis of human peripheral blood-derived B cell malignancy models using Gradientech’s CellDirector® 2D assay is now released.
Pre-coating with fibronectin before cell seeding was crucial for both MEC-1 and MAVER-1 cells.
The new protocol can be found as a whole amongst our Application Protocols.
Gradientech thanks Pavlina Janovská, MSc at the Dept. of Experimental Biology, Masarykova Universita, Brno, Czech Republic, for sharing the protocol with other CellDirector users.